Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
80%
Neutralization
61%
Neutralizing Antibody
43%
COVID-19
40%
Monoclonal Antibody
38%
Receptor Binding
34%
Breakthrough Infection
29%
Antibody Response
24%
Immune Response
23%
Epitope
18%
Titer
17%
T Cell
17%
Omicron Coronavirus Variant
16%
Amino Terminal Sequence
16%
Natural Killer Cell
14%
T Cell Receptor
14%
Macrophage
14%
Cell Function
14%
Adenovirus Vaccine
14%
Capsid
14%
Humoral Immunity
14%
Cell Activation
12%
Intravenous Immunoglobulin
11%
Memory B Cell
9%
B Cell
9%
Adenoviridae
8%
Virus
8%
Dynamics
7%
Myeloid
5%
Adenovirus Vector
5%
Proinflammatory Cytokine
5%
Cytokine Production
5%
Adoptive Immunity
5%
Medicine and Dentistry
COVID-19
32%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
T Cell
17%
T Lymphocyte Receptor
14%
Angiotensin I
14%
Dipeptidyl Carboxypeptidase
14%
Cardiometabolic Risk
14%
Adipose Tissue
14%
Lymphocyte Antigen Receptor
14%
Adenovirus Vaccine
14%
Humoral Immunity
14%
Virus Capsid
14%
Immunoglobulin
11%
Adenoviridae
8%
B Cell
7%
Infection
6%
Adenovirus Vector
5%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
22%
Spike
14%
Enzyme
14%
Angiotensin
14%
T Cell
14%
T Cell Receptor
11%
Memory B Cell
9%
Immune Response
9%
Intravenous Immunoglobulin
8%
B Cell
5%